PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 115 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2013. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $35,478,000 | +122.8% | 150,259 | +78.6% | 0.09% | +125.0% |
| Q4 2014 | $15,927,000 | -87.0% | 84,150 | -83.6% | 0.04% | -86.9% |
| Q3 2014 | $122,080,000 | -31.7% | 511,716 | -81.1% | 0.31% | +50.0% |
| Q2 2014 | $178,678,000 | +24.7% | 2,710,012 | +96.9% | 0.20% | -37.4% |
| Q1 2014 | $143,303,000 | -7.3% | 1,376,059 | -7.9% | 0.33% | -5.2% |
| Q4 2013 | $154,620,000 | +79.9% | 1,493,477 | -6.7% | 0.34% | +73.7% |
| Q3 2013 | $85,926,000 | +1282.6% | 1,601,301 | +1043.2% | 0.20% | +1314.3% |
| Q2 2013 | $6,215,000 | – | 140,076 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 507,500 | $121,074,000 | 24.90% |
| BB BIOTECH AG | 476,991 | $113,796,000 | 4.63% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $1,356,668,000 | 3.35% |
| WEATHERBIE CAPITAL, LLC | 101,055 | $24,109,000 | 2.26% |
| Avalon Global Asset Management LLC | 16,000 | $3,817,000 | 2.24% |
| Redmile Group, LLC | 51,025 | $12,173,000 | 1.41% |
| Fernwood Investment Management, LLC | 6,700 | $1,598,000 | 1.38% |
| Iguana Healthcare Management, LLC | 10,000 | $2,386,000 | 1.27% |
| LMR Partners LLP | 56,632 | $13,510,000 | 1.08% |
| FRANKLIN STREET ADVISORS INC /NC | 21,990 | $5,246,000 | 1.00% |